Michele Trimboli

18PUBLICATIONS
97CO-AUTHORS
Gene and molecular therapyTraditional Chinese medicine and treatmentsEpidemiological methodsDisease surveillanceMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 26, 2026
SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

|Jun 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort.

|Mar 25, 2026
The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Luigi Francesco Iannone, Gabriele Sebastianelli, Federico De Santis

|Feb 13, 2026
Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Luigi Francesco Iannone, Elisa Maria Piella, Danilo Antonio Montisano

|Jan 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo

|Dec 25, 2025
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study).

Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado

Pageof 3

Frequent Collaborators

7 joint publications

Simona Sacco

6 joint publications

Raffaele Ornello

6 joint publications

Cristina Tassorelli

5 joint publications

Roberto De Icco